SHARMILA ANANDASABAPATHY

Concepts (304)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Esophageal Neoplasms
36
2024
372
5.700
Why?
Barrett Esophagus
29
2024
340
4.700
Why?
Esophagoscopy
24
2024
156
4.340
Why?
Optical Imaging
10
2020
65
3.350
Why?
Precancerous Conditions
12
2020
282
2.850
Why?
Adenocarcinoma
21
2022
1023
2.140
Why?
Esophagus
12
2020
216
2.070
Why?
Colonoscopy
8
2018
236
1.990
Why?
Microscopy
10
2024
116
1.780
Why?
Colorectal Neoplasms
9
2019
574
1.760
Why?
Endoscopy, Gastrointestinal
8
2020
241
1.680
Why?
Endoscopy
8
2024
280
1.600
Why?
Early Detection of Cancer
10
2024
361
1.450
Why?
Colonic Neoplasms
3
2019
248
1.190
Why?
Image Enhancement
9
2015
163
1.130
Why?
Colonic Polyps
4
2018
78
1.060
Why?
Gastrointestinal Neoplasms
4
2020
79
0.940
Why?
Adenoma
3
2015
129
0.910
Why?
Microscopy, Confocal
12
2019
348
0.900
Why?
Gastroenterology
4
2021
196
0.820
Why?
Internationality
2
2021
131
0.820
Why?
Carcinoma, Squamous Cell
6
2024
670
0.820
Why?
Physicians, Women
2
2021
47
0.770
Why?
Developing Countries
1
2024
270
0.760
Why?
Sensitivity and Specificity
15
2020
2051
0.760
Why?
Biopsy
9
2024
1236
0.750
Why?
Microscopy, Fluorescence
4
2015
325
0.710
Why?
Image Interpretation, Computer-Assisted
5
2018
217
0.670
Why?
Orthomyxoviridae
1
2019
50
0.620
Why?
Laboratories
1
2019
82
0.600
Why?
Neoplasms
3
2024
2792
0.600
Why?
Molecular Imaging
3
2013
61
0.590
Why?
Physician's Role
2
2021
166
0.580
Why?
Humans
78
2024
124906
0.570
Why?
Carcinoma in Situ
1
2018
71
0.570
Why?
Intestinal Polyps
2
2015
29
0.550
Why?
Gastroesophageal Reflux
3
2009
295
0.520
Why?
Laser Therapy
2
2009
249
0.510
Why?
Neoplasms, Squamous Cell
1
2015
8
0.490
Why?
Gastroscopy
2
2013
100
0.480
Why?
Endoscopes
4
2019
20
0.480
Why?
Mucous Membrane
3
2012
90
0.470
Why?
Societies, Medical
1
2018
695
0.460
Why?
China
5
2024
245
0.450
Why?
Proctoscopy
1
2013
6
0.440
Why?
Population Surveillance
1
2016
388
0.440
Why?
Adenomatous Polyps
1
2013
13
0.420
Why?
Anus Neoplasms
2
2023
38
0.420
Why?
Influenza, Human
1
2019
658
0.400
Why?
Rectal Neoplasms
1
2013
79
0.400
Why?
Cell Transformation, Neoplastic
2
2015
618
0.400
Why?
Health Care Costs
1
2015
371
0.390
Why?
Cryosurgery
1
2012
47
0.380
Why?
Endosonography
3
2019
79
0.370
Why?
Gastroenterologists
2
2021
11
0.370
Why?
Stomach
1
2013
269
0.350
Why?
Colitis, Ulcerative
2
2012
205
0.340
Why?
Lasers, Gas
1
2009
7
0.320
Why?
Middle Aged
21
2024
26879
0.310
Why?
Myocarditis
2
2002
130
0.310
Why?
Digestive System Surgical Procedures
2
2008
85
0.310
Why?
Iodides
3
2024
15
0.300
Why?
Endoscopic Mucosal Resection
2
2022
68
0.300
Why?
Fluorescent Dyes
5
2013
261
0.300
Why?
Fiber Optic Technology
5
2024
46
0.290
Why?
Autoimmune Diseases
2
2002
251
0.290
Why?
Tomography, Optical Coherence
6
2013
516
0.280
Why?
Catheter Ablation
2
2022
236
0.270
Why?
Esophageal pH Monitoring
1
2006
3
0.270
Why?
Hernia, Hiatal
1
2007
55
0.270
Why?
Image Processing, Computer-Assisted
4
2024
580
0.260
Why?
Aged, 80 and over
8
2015
6588
0.260
Why?
Electric Impedance
1
2006
58
0.260
Why?
HIV Infections
3
2023
1894
0.250
Why?
Coloring Agents
3
2024
80
0.250
Why?
Female
27
2024
66678
0.250
Why?
Male
25
2024
61395
0.240
Why?
Aged
13
2024
19835
0.230
Why?
Deglutition Disorders
1
2006
132
0.230
Why?
Methylene Blue
1
2024
13
0.230
Why?
Observer Variation
3
2013
297
0.220
Why?
Neoplasm Staging
5
2019
1278
0.220
Why?
Predictive Value of Tests
4
2024
2154
0.210
Why?
Equipment Design
5
2024
596
0.210
Why?
Diagnosis, Differential
3
2015
1885
0.210
Why?
Body Mass Index
1
2009
1563
0.200
Why?
Career Choice
2
2021
146
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2006
352
0.200
Why?
Diagnostic Imaging
3
2023
277
0.200
Why?
Social Determinants of Health
1
2023
124
0.190
Why?
Women, Working
1
2021
9
0.190
Why?
Metaplasia
6
2022
213
0.180
Why?
Algorithms
5
2018
1624
0.180
Why?
Colonoscopes
2
2013
10
0.180
Why?
Prospective Studies
6
2015
6155
0.180
Why?
Stomach Neoplasms
2
2019
545
0.180
Why?
Job Satisfaction
1
2021
79
0.170
Why?
Cardiomyopathy, Dilated
1
2002
212
0.170
Why?
Pancreas
2
2012
218
0.170
Why?
Software
2
2024
683
0.160
Why?
Kenya
1
2019
52
0.160
Why?
Virus Diseases
1
2002
280
0.160
Why?
Intravital Microscopy
2
2016
16
0.160
Why?
United States
6
2024
10909
0.160
Why?
Carbon Dioxide
2
2012
277
0.160
Why?
Robotics
2
2024
108
0.160
Why?
Global Health
1
2024
561
0.160
Why?
Pilot Projects
4
2016
1397
0.160
Why?
Mass Screening
3
2019
783
0.150
Why?
Costs and Cost Analysis
1
2019
164
0.150
Why?
Virtual Reality
1
2018
28
0.150
Why?
Prognosis
4
2015
4631
0.150
Why?
Preceptorship
1
2018
32
0.150
Why?
Chemoprevention
2
2016
58
0.150
Why?
Adult
12
2024
29576
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2024
850
0.140
Why?
Feasibility Studies
5
2015
759
0.140
Why?
Esophagectomy
2
2016
64
0.140
Why?
Obesity
1
2009
2237
0.140
Why?
Manikins
1
2018
135
0.140
Why?
Swine
3
2012
1192
0.140
Why?
Forecasting
1
2018
351
0.140
Why?
Real-Time Polymerase Chain Reaction
1
2019
502
0.140
Why?
Teaching
1
2018
190
0.130
Why?
Models, Animal
2
2009
465
0.130
Why?
Computers, Handheld
1
2016
33
0.120
Why?
Epithelial Cells
1
2020
909
0.120
Why?
Cohort Studies
3
2019
4808
0.120
Why?
Proflavine
2
2012
2
0.120
Why?
Capsule Endoscopes
1
2015
1
0.120
Why?
Attitude of Health Personnel
1
2021
664
0.120
Why?
Models, Economic
1
2015
51
0.120
Why?
Colon
2
2018
349
0.120
Why?
Proton Pump Inhibitors
2
2009
258
0.120
Why?
Video Recording
2
2013
182
0.120
Why?
Markov Chains
1
2015
84
0.120
Why?
Quality-Adjusted Life Years
1
2015
111
0.120
Why?
Reproducibility of Results
4
2015
2881
0.110
Why?
Proctoscopes
1
2013
2
0.110
Why?
Natural Orifice Endoscopic Surgery
1
2015
64
0.110
Why?
Comparative Effectiveness Research
1
2013
68
0.110
Why?
Contrast Media
3
2011
473
0.100
Why?
Risk Factors
4
2019
10285
0.100
Why?
Oropharyngeal Neoplasms
1
2015
165
0.100
Why?
Hyperplasia
1
2013
208
0.100
Why?
Retrospective Studies
7
2022
16345
0.100
Why?
Rectum
1
2013
100
0.100
Why?
Cost-Benefit Analysis
1
2015
509
0.100
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2012
28
0.100
Why?
Animals
7
2024
34057
0.100
Why?
Optical Fibers
2
2024
18
0.100
Why?
4-Chloro-7-nitrobenzofurazan
1
2011
3
0.100
Why?
Deoxyglucose
1
2011
33
0.090
Why?
Intestinal Mucosa
2
2013
776
0.090
Why?
Risk Assessment
4
2019
3449
0.090
Why?
Gastrointestinal Tract
1
2013
215
0.090
Why?
Surgical Instruments
1
2010
56
0.090
Why?
Adrenergic Antagonists
2
2002
4
0.090
Why?
Case-Control Studies
2
2009
3289
0.090
Why?
Light
1
2010
174
0.080
Why?
Calcium Channel Blockers
2
2002
115
0.080
Why?
Career Mobility
2
2021
50
0.080
Why?
Pattern Recognition, Automated
1
2010
49
0.080
Why?
Mobile Applications
2
2024
89
0.080
Why?
Needles
1
2009
51
0.080
Why?
Administration, Topical
2
2024
141
0.080
Why?
Pancreatic Neoplasms
2
2012
691
0.080
Why?
Time Factors
2
2019
6320
0.080
Why?
Biopsy, Fine-Needle
1
2009
116
0.080
Why?
Loss of Heterozygosity
1
2009
125
0.080
Why?
ROC Curve
3
2017
571
0.080
Why?
Chromosomes, Human, Pair 1
1
2009
140
0.080
Why?
Age Factors
1
2015
2823
0.080
Why?
Carcinoma, Neuroendocrine
1
2008
34
0.070
Why?
Incidence
2
2009
3140
0.070
Why?
Sex Distribution
1
2009
303
0.070
Why?
Cross-Sectional Studies
2
2024
3436
0.070
Why?
Age Distribution
1
2009
415
0.070
Why?
Pregnancy Complications
2
2024
512
0.070
Why?
Spectrum Analysis
1
2008
62
0.070
Why?
Biopsy, Needle
1
2008
231
0.070
Why?
Endoscopy, Digestive System
1
2008
149
0.070
Why?
Head and Neck Neoplasms
1
2012
502
0.070
Why?
Comorbidity
2
2009
1532
0.070
Why?
Heartburn
1
2006
15
0.070
Why?
Sex Factors
2
2021
1287
0.070
Why?
Immunosuppressive Agents
2
2002
649
0.060
Why?
Omeprazole
1
2006
97
0.060
Why?
Hydrogen-Ion Concentration
1
2006
432
0.060
Why?
Quality of Life
1
2015
1944
0.060
Why?
Liver
1
2012
1737
0.060
Why?
Mice
3
2016
17583
0.060
Why?
Gambia
1
2024
28
0.060
Why?
Immunohistochemistry
1
2008
1691
0.060
Why?
Smartphone
1
2024
37
0.060
Why?
Printing, Three-Dimensional
1
2024
69
0.050
Why?
Enzyme Inhibitors
1
2006
579
0.050
Why?
Obstetric Labor Complications
1
2024
93
0.050
Why?
Surveys and Questionnaires
2
2024
3729
0.050
Why?
Anal Canal
1
2023
81
0.050
Why?
Single-Blind Method
2
2013
237
0.050
Why?
Practice Guidelines as Topic
1
2009
1269
0.050
Why?
MicroRNAs
1
2009
835
0.050
Why?
Treatment Outcome
4
2022
12405
0.050
Why?
Liver Neoplasms
1
2012
1314
0.050
Why?
Point-of-Care Systems
1
2024
172
0.050
Why?
Parental Leave
1
2021
4
0.050
Why?
Cell Nucleus
1
2024
678
0.050
Why?
Logistic Models
1
2006
1812
0.050
Why?
Prenatal Care
1
2024
347
0.050
Why?
Disease Progression
3
2016
2060
0.040
Why?
Reproductive Techniques, Assisted
1
2021
70
0.040
Why?
Radiation Exposure
1
2021
42
0.040
Why?
Severity of Illness Index
1
2009
2902
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
224
0.040
Why?
Pregnancy
2
2024
7174
0.040
Why?
Occupational Exposure
1
2021
127
0.040
Why?
Radiation Injuries
1
2021
142
0.040
Why?
Fungal Vaccines
1
1999
1
0.040
Why?
Immunoglobulin Idiotypes
1
1999
11
0.040
Why?
Antibodies, Fungal
1
1999
13
0.040
Why?
Cryptococcus neoformans
1
1999
20
0.040
Why?
Mice, Inbred BALB C
1
2002
1003
0.040
Why?
Mentors
1
2021
148
0.040
Why?
Tetanus Toxoid
1
1999
45
0.040
Why?
Salaries and Fringe Benefits
1
2019
28
0.040
Why?
Follow-Up Studies
2
2013
5165
0.040
Why?
Biomarkers, Tumor
1
2007
1492
0.040
Why?
Watchful Waiting
1
2019
70
0.040
Why?
CD4 Lymphocyte Count
1
2019
231
0.040
Why?
Delivery of Health Care
1
2024
607
0.040
Why?
Polysaccharides
1
1999
140
0.040
Why?
Drug Therapy, Combination
1
2002
1165
0.040
Why?
Survival Analysis
1
2002
1507
0.040
Why?
Autoimmunity
1
1999
172
0.040
Why?
Fellowships and Scholarships
1
2021
281
0.040
Why?
Immunization, Passive
1
1998
120
0.040
Why?
Regression Analysis
1
2019
780
0.040
Why?
Randomized Controlled Trials as Topic
1
2002
1116
0.030
Why?
Artificial Intelligence
1
2020
241
0.030
Why?
Alcohol Drinking
1
2019
343
0.030
Why?
Africa, Western
1
2016
12
0.030
Why?
Education, Medical, Graduate
1
2021
518
0.030
Why?
Education, Nursing
1
2016
12
0.030
Why?
Adjuvants, Immunologic
1
1998
383
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
1998
305
0.030
Why?
Kaplan-Meier Estimate
2
2008
1054
0.030
Why?
Neck Dissection
1
2015
18
0.030
Why?
Proportional Hazards Models
1
2019
1358
0.030
Why?
Emergency Treatment
1
2016
87
0.030
Why?
In Situ Hybridization, Fluorescence
1
2017
762
0.030
Why?
Nitric Oxide
1
1998
445
0.030
Why?
Equipment Failure Analysis
1
2015
85
0.030
Why?
Combined Modality Therapy
2
2008
1240
0.030
Why?
Mouth
1
2015
61
0.030
Why?
Young Adult
2
2024
9051
0.030
Why?
Waiting Lists
1
2016
227
0.030
Why?
Smoking
1
2019
1046
0.030
Why?
Narrow Band Imaging
1
2013
2
0.030
Why?
Interferometry
1
2013
26
0.030
Why?
Optical Phenomena
1
2013
10
0.030
Why?
Antiviral Agents
1
1998
750
0.030
Why?
Learning Curve
1
2012
53
0.020
Why?
Education, Medical
1
2016
288
0.020
Why?
Fluorescence
1
2012
96
0.020
Why?
Disease Models, Animal
1
2002
4353
0.020
Why?
Hospitals
1
2014
388
0.020
Why?
Drug Evaluation, Preclinical
1
2011
152
0.020
Why?
In Vitro Techniques
1
2012
970
0.020
Why?
Color
1
2010
31
0.020
Why?
Area Under Curve
1
2011
318
0.020
Why?
Goblet Cells
1
2011
103
0.020
Why?
Adolescent
2
2024
19343
0.020
Why?
Staining and Labeling
1
2010
186
0.020
Why?
Helicobacter pylori
1
2019
1319
0.020
Why?
Calgranulin B
1
2009
9
0.020
Why?
Keratin-5
1
2009
9
0.020
Why?
Cornified Envelope Proline-Rich Proteins
1
2009
19
0.020
Why?
Clinical Competence
1
2016
1000
0.020
Why?
Crohn Disease
1
2012
283
0.020
Why?
DNA Primers
1
2009
657
0.020
Why?
Radiotherapy
1
2008
135
0.020
Why?
Veterans
1
2019
1753
0.020
Why?
Lymph Nodes
1
2009
383
0.020
Why?
Neoplasm Invasiveness
1
2009
620
0.020
Why?
Cyclin D1
1
2007
112
0.020
Why?
Carcinoma
1
2009
286
0.020
Why?
Early Diagnosis
1
2007
181
0.020
Why?
Disease-Free Survival
1
2008
899
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
1288
0.020
Why?
NF-kappa B
1
2007
455
0.010
Why?
RNA, Messenger
1
2009
2815
0.010
Why?
Mice, Inbred C3H
1
1999
115
0.010
Why?
Immunoglobulin Variable Region
1
1999
52
0.010
Why?
Vaccines, Conjugate
1
1999
78
0.010
Why?
Antineoplastic Agents
1
2008
1687
0.010
Why?
Mice, Inbred Strains
1
1999
308
0.010
Why?
DNA, Complementary
1
1999
461
0.010
Why?
Rabbits
1
1999
710
0.010
Why?
Lupus Erythematosus, Systemic
1
1999
192
0.010
Why?
Base Sequence
1
1999
3090
0.010
Why?
Signal Transduction
1
2007
4496
0.010
Why?
Molecular Sequence Data
1
1999
3877
0.010
Why?
Antibodies, Monoclonal
1
1999
1031
0.010
Why?
ANANDASABAPATHY's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (304)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_